
News|Articles|May 1, 2002
Longer is better for thromboembolism prophylaxis after cancer surgery
Enoxaparin (Lovenox) is typically used during hospitalization after orthopedic or abdominal surgery. Recent studies of its use after orthopedic surgery have shown that extending administration of the low-molecular-weight heparin after hospital discharge significantly reduces the frequency of deep-vein thrombosis (DVT). A new study confirms this is also the case for abdominal surgery for cancer, which carries a high risk of this complication.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Music and painting dual art therapy improves cognitive and social functions of hospitalized schizophrenia patients, study suggests
2
Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026
3
Early ctDNA clearance signals stronger Ordspono responses in relapsed lymphomas
4
Low uptake of shingles vaccine despite strong value proposition for older adults
5






















































